Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're using licensed semaglutide for weight management in the UK, the syringe question has a short, practical answer: you don't need one. Wegovy is supplied as a pre-filled, pre-dosed injection pen — the needle is built in, the dose is set, and there is nothing to draw up or measure. Understanding why this matters, and what to do if you've read conflicting advice online, is worth a few minutes of your time. Semaglutide (Wegovy) is a prescription-only medicine; a qualified prescriber assesses suitability before any supply.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When Wegovy arrives through a regulated UK pharmacy, it comes as a pre-filled injection pen containing a fixed amount of semaglutide, 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, or 2.4 mg, depending on where you are in your titration schedule. The pen holds four weekly doses. You attach a fresh needle (supplied with, or purchased separately for, the pen) immediately before each injection, dial the dose, press the button, and that is the full process. There is no vial, no separate syringe, and no measurement involved.
This matters because the pre-filled format is a deliberate safety feature. Semaglutide is active in very small amounts. Even a small miscalculation when drawing from a vial (the way some compounded or counterfeit products are sold) can result in a significant overdose or underdose. The MHRA has warned repeatedly about fake weight-loss pens sold online, some of which have required hospital treatment after use. You can read the MHRA's guidance on this directly at the Yellow Card reporting portal, which also accepts reports of suspect sellers.
For a fuller picture of how Wegovy works as a medicine (including how it differs from other semaglutide products) the Wegovy overview on the nume website covers the licensed indications clearly.
The needle you use with a Wegovy pen is a pen needle, not a syringe. The two words are sometimes used interchangeably online, which causes real confusion. A pen needle screws onto the pen's needle thread; a syringe is a separate barrel-and-plunger device for drawing liquid from a vial. They are not interchangeable.
Your prescriber or the NHS semaglutide patient guide will confirm the correct pen-needle gauge and length for the Wegovy pen. A finer needle (higher gauge number) tends to cause less discomfort; shorter needles work well for most injection sites. The injection goes under the skin (subcutaneous, not into muscle) at the abdomen, thigh, or upper arm, rotating sites each week.
If you're curious about how syringe size is discussed in the context of injectable weight-loss medicines more broadly, the semaglutide syringe size guide explains the terminology and why it applies to pen needles rather than traditional syringes.
Much of the online content about syringes for semaglutide originates in the United States, where compounded semaglutide) mixed in a separate pharmacy and supplied in a vial, has been prescribed during periods of shortage. In that context, a 1 ml insulin syringe with a fine-gauge needle (commonly cited as 27–31 gauge, 4–8 mm) is used to draw the dose. That content is not applicable to UK practice.
In the UK, pre-filled semaglutide supplied through a GPhC-registered pharmacy is the only legitimate route to licensed weight-loss treatment, and if you want to understand how a semaglutide prefilled syringe differs from the pen device you receive, that page explains the distinction clearly. There is no licensed compounded semaglutide vial product in the UK. If you have sourced a vial-based product, it has not been approved by the MHRA for this use, and the instructions circulating online for drawing it up carry genuine risk.
Cost is a real factor in why some people look for alternatives. The Wegovy pricing page sets out what a private prescription actually includes, which is worth reading before drawing any conclusions about value.
If you are already on Wegovy and have a question about your pen or needle (whether that's a blocked needle, a missed dose, or switching pens) the right source is your prescriber or the Patient Information Leaflet that came with your medicine. The nume FAQ page covers common queries too.
For anyone taking other medicines alongside semaglutide, it is worth knowing that interactions do exist. A prescriber reviews these as part of the assessment process; for one example, the question of taking semaglutide with methotrexate is one our prescribers consider carefully on a case-by-case basis.
The broader landscape of what licensed weight-loss treatment involves (including how the consultation works and what to expect on delivery (your pen arrives via tracked DPD in plain, unbranded packaging, the same day it's dispatched)) is covered on the weight-loss treatments page. If you'd like a prescriber to review your situation, that is the place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.